Dr. Rui Zhang 张睿
Chief Physician
Department of Colorectal Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Treatment of intestinal malignant tumors.
Dr. Zhang is Chief Physician and Deputy Director of the Colorectal Surgery Department at Liaoning Cancer Hospital & Institute, and a doctoral supervisor. Dr. Zhang has led six provincial-level research projects, published 46 papers (28 indexed in SCI), authored six monographs, and received three provincial awards.
Professional roles
- Member, Chinese Medical Association
- Standing Committee Member, Tumor Imaging Diagnosis Professional Committee, China Research Hospital Association
- Leader, Liaoning Study Group on Neuroendocrine Tumors, China International Exchange and Promotion Association for Medical and Health Care
- Vice Chair, Youth Committee on Neuroendocrine Tumors, China International Exchange and Promotion Association for Medical and Health Care
Name order: in Chinese the family name comes first (Zhang Rui). Papers usually list the name as Rui Zhang or Zhang R.
Selected publications
111 papers on PubMed matched by name and affiliation; 51 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Surg, 2025 (senior author): Development and validation of a post-chemoradiotherapy prognostic model in patients with locally advanced rectal cancer who underwent radical surgery after neoadjuvant chemoradiotherapy: a retrospective, multicenter, cohort study. PubMed 41347259
- J Obstet Gynaecol, 2023 (senior author): Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers. PubMed 36880525
- Int J Surg, 2023 (first author): How to reasonably deal with zero-events in meta-analysis of surgery-related outcomes? Oncologic outcomes of intersphincteric resection vs. abdominoperineal resection for lower rectal cancer: a systematic review and meta-analysis. PubMed 37300885
- Int J Surg, 2023 (first author): Laboratory biomarker as an alternative to low-dose computed tomography for the diagnosis of suspected appendicitis? Circulating fibrocyte percentage and neutrophil-lymphocyte ratio are accurate biomarkers of uncomplicated and complicated appendicitis: a prospective cohort study. PubMed 37010153
- Front Genet, 2022 (senior author): The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis. PubMed 36339000
- Front Genet, 2022 (senior author): The clinicopathological significances and related signal pathways of BTG3 mRNA expression in cancers: A bioinformatics analysis. PubMed 36186486
- Oncol Rep, 2022 (senior author): [Retracted] MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3. PubMed 35169854
- Oncol Rep, 2022 (senior author): [Retracted] MicroRNA‑485 plays tumour‑suppressive roles in colorectal cancer by directly targeting GAB2. PubMed 35088894
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion